Submit Deal

Submit Deal

Cover Image Sujal Shah

Sujal Shah

President and CEO at CYMABAY THERAPEUTICS

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 3.40 B

Avg. Deal Size£ 3.40 B

Market Context

Sort

12 Feb 2024|United States|Pharmaceuticals

Target: CYMABAY THERAPEUTICS

Bidder: GILEAD SCIENCES

11 Service Providers

6 Target | 5 Bidder

37 Dealmakers

18 Target | 19 Bidder

£ 3.40 B

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite